PUBLISHER: Coherent Market Insights | PRODUCT CODE: 2107824
PUBLISHER: Coherent Market Insights | PRODUCT CODE: 2107824
Transient Elastography Devices Market is estimated to be valued at USD 529.8 Mn in 2026 and is expected to reach USD 884.9 Mn by 2033, growing at a compound annual growth rate (CAGR) of 7.61% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 529.8 Mn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 7.61% | 2033 Value Projection: | USD 884.9 Mn |
Elastography is a medical imaging modality that maps the elastic properties and stiffness of soft tissues such as liver. Elastography is also known as liver elastography. It is a type of imaging test that checks the liver for fibrosis. Fibrosis is a condition that reduces blood flow to and inside the liver. This causes the build-up of scar tissue. Fibrosis can lead to serious complications in the liver. An elastography is used to diagnose fatty liver disease (FLD) and fibrosis. Fatty liver disease is a condition in which normal liver tissue is replaced by fat. This fat can lead to cell death and fibrosis in the liver. Transient elastography (TE) devices measures the stiffness of liver. TE devices use vibration controlled transient elastography (VCTE) and controlled attenuation parameters. Transient elastography devices comes in standalone and portable modality.
Increasing number of product launches is expected to drive the global transient elastography devices market. For instance, in August 2019, Wuxi Hisky Medical Technologies Co., Ltd., a China-based medical device company, launched a new product series, iLivTouch, which uses multichannel imaging guided transient elastography to assess the state of hepatic fibrosis and steatosis.
However, growth of the global transient elastography devices market could also be hampered over the forecast period, owing to the availability of alternate methods. For instance, transient elastography devices cannot be used for people who are suffering from obesity, ascites, and narrow intercostal spaces. So, in such patients, alternate technologies such as shear wave elastography (SWE) and magnetic resonance elastography (MRE) are available in the market.